TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine
Condition(s):High Frequency Episodic Migraine and Chronic MigraineLast Updated:May 13, 2016Completed
Hide Studies Not Open or Pending
Condition(s):High Frequency Episodic Migraine and Chronic MigraineLast Updated:May 13, 2016Completed
Condition(s):Migraine Disorders; Migraine With Aura; Migraine Without Aura; Brain DiseasesLast Updated:February 6, 2024Recruiting
Condition(s):Migraine in Children; Migraine With AuraLast Updated:July 29, 2021Completed
Condition(s):MigraineLast Updated:June 1, 2020Withdrawn
Condition(s):Migraine DisordersLast Updated:January 16, 2024Recruiting
Condition(s):MigraineLast Updated:October 8, 2020Completed
Condition(s):Migraine Disorders; Chronic Migraine; Episodic MigraineLast Updated:January 16, 2024Recruiting
Condition(s):Migraine Without AuraLast Updated:February 11, 2021Unknown status
Condition(s):Migraine Disorders; Sleep DisorderLast Updated:February 6, 2024Recruiting
Condition(s):MigraineLast Updated:March 17, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.